Attenzione! I contenuti di questa pagina sono disponibili solo nelle seguenti lingue: Inglese
Comecer announces its support of Serum Institute of India Pvt. Ltd (vaccine manufacturer) in the global fight against dangerous diseases. Serum will produce vaccines for recombinant Bacillus Calmette–Guérin (BCG) for tuberculosis, monoclonal antibodies vaccines, and vaccines for Pertussis, Diphtheria, and Tetanus.
Serum Institute of India is the world’s largest vaccine manufacturer based on the more than 1.5 billion doses produced and sold globally. Ranked as India’s No. 1 biotechnology company, manufacturing highly specialized life-saving biologics, like vaccines, using cutting edge genetic and cell-based technologies, antisera, and other medical specialties.
Comecer leads the field in designing and manufacturing isolation equipment and systems intended for pharmaceutical and cell therapy applications. For this reason, Serum chose Comecer as its principal partner for the supply of vaccine isolation technology.
Thanks to its Modular Aseptic Technology program, Comecer developed and supplied in 6 months fully customized equipment designed according to the Covid-19 vaccine manufacturing process.
The equipment was studied and designed according to the actual customer process with special consideration to operator safety and ergonomics. All the instruments necessary for vaccine manufacturing and harvesting are integrated into the isolator for Grade A environmental control during the entire process.